Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Cited In for PubMed (Select 9544766)

1.

A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.

Pradella LM, Evangelisti C, Ligorio C, Ceccarelli C, Neri I, Zuntini R, Amato LB, Ferrari S, Martelli AM, Gasparre G, Turchetti D.

BMC Cancer. 2014 Feb 6;14:70. doi: 10.1186/1471-2407-14-70.

2.

Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations.

Tulchin N, Ornstein L, Dikman S, Strauchen J, Jaffer S, Nagi C, Bleiweiss I, Kornreich R, Edelmann L, Brown K, Bodian C, Nair VD, Chambon M, Woods NT, Monteiro AN.

Cancer Cell Int. 2013 Jul 15;13(1):70. doi: 10.1186/1475-2867-13-70.

3.

The 2013 Genetics Society of America Medal: Elaine A. Ostrander.

Schimenti J, Halpern M.

Genetics. 2013 May;194(1):5-7. doi: 10.1534/genetics.113.150672. No abstract available.

4.

Intraductal papilloma of the breast in association with preoncogenic gene of breast cancer.

Khammapirad T, Prueksadee J, Diaz-Arrastia C, Botting SK, Leonard M, Bonoan-Deomampo L, Eltorky MA.

Asian Pac J Trop Biomed. 2011 Apr;1(2):161-3. doi: 10.1016/S2221-1691(11)60017-8.

5.

BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycle.

Jiang G, Plo I, Wang T, Rahman M, Cho JH, Yang E, Lopez BS, Xia F.

J Biol Chem. 2013 Mar 29;288(13):8966-76. doi: 10.1074/jbc.M112.412650. Epub 2013 Jan 23.

6.

Conditional and Marginal Estimates in Case-Control Family Data - Extensions and Sensitivity Analyses.

Gorfine M, De-Picciotto R, Hsu L.

J Stat Comput Simul. 2012 Oct 1;82(10):1449-1470. Epub 2012 Jul 5.

7.

Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.

Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2560-71. doi: 10.1158/1055-9965.EPI-11-0781. Epub 2011 Sep 29.

8.

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM.

Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010. Erratum in: Cancer Cell. 2013 Apr 15;23(4):557.

9.

A long AAAG repeat allele in the 5' UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells.

Galindo CL, McCormick JF, Bubb VJ, Abid Alkadem DH, Li LS, McIver LJ, George AC, Boothman DA, Quinn JP, Skinner MA, Garner HR.

Breast Cancer Res Treat. 2011 Nov;130(1):41-8. doi: 10.1007/s10549-010-1237-9. Epub 2010 Dec 10.

11.

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C, Mitchell G.

Breast Cancer Res. 2008;10(6):216. doi: 10.1186/bcr2194. Epub 2008 Nov 28. Review.

12.

Validity of models for predicting BRCA1 and BRCA2 mutations.

Parmigiani G, Chen S, Iversen ES Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM.

Ann Intern Med. 2007 Oct 2;147(7):441-50.

13.

Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women.

Friedrichsen DM, Malone KE, Doody DR, Daling JR, Ostrander EA.

Breast Cancer Res. 2004;6(6):R629-35. Epub 2004 Sep 22.

14.

Homologous Recombination and Its Role in Carcinogenesis.

Bishop AJ, Schiestl RH.

J Biomed Biotechnol. 2002;2(2):75-85.

15.

BRCA2 T2722R is a deleterious allele that causes exon skipping.

Fackenthal JD, Cartegni L, Krainer AR, Olopade OI.

Am J Hum Genet. 2002 Sep;71(3):625-31. Epub 2002 Jul 19. Erratum in: Am J Hum Genet. 2003 Dec;73(6):1477.

16.

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.

Yassaee VR, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi MA, Hornby DP, Dalton A.

Breast Cancer Res. 2002;4(4):R6. Epub 2002 Apr 16.

17.

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.

Bergthorsson JT, Ejlertsen B, Olsen JH, Borg A, Nielsen KV, Barkardottir RB, Klausen S, Mouridsen HT, Winther K, Fenger K, Niebuhr A, Harboe TL, Niebuhr E.

J Med Genet. 2001 Jun;38(6):361-8.

18.

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.

Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H.

Br J Cancer. 2001 Mar 2;84(5):704-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk